Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPX-115 in Partial-Thickness Rotator Cuff Tear
NCT04470167Phase 2Completed
- Sponsor
- Tego Science
- Start
- Oct 2020
- Primary completion
- Feb 2022
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in partial-thickness rotator cuff tear (PRCT) comparing TPX-115 with Placebo (2 arms). Primary endpoint: American Shoulder and Elbow Surgeons Score at 24 weeks. Started Oct 2020; status: completed.
02
Drugs
TPX-115
03
Conditions
partial-thickness rotator cuff tear (PRCT)
Beyond the preview
Go deeper on NCT04470167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470167.